[go: up one dir, main page]

RU93004484A - DERIVATIVES OF PYRAZOLES, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS - Google Patents

DERIVATIVES OF PYRAZOLES, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS

Info

Publication number
RU93004484A
RU93004484A RU93004484/04A RU93004484A RU93004484A RU 93004484 A RU93004484 A RU 93004484A RU 93004484/04 A RU93004484/04 A RU 93004484/04A RU 93004484 A RU93004484 A RU 93004484A RU 93004484 A RU93004484 A RU 93004484A
Authority
RU
Russia
Prior art keywords
pharmaceutical compositions
derivatives
pyrazoles
production
inflammatory
Prior art date
Application number
RU93004484/04A
Other languages
Russian (ru)
Other versions
RU2128172C1 (en
Inventor
Мацуо Масиаки
Цудзи Кийося
Ошно Такаси
Кониси Нобукийо
Original Assignee
Фудзисава Фармасьютикал Ко, ЛтД
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929202442A external-priority patent/GB9202442D0/en
Priority claimed from GB929220427A external-priority patent/GB9220427D0/en
Application filed by Фудзисава Фармасьютикал Ко, ЛтД filed Critical Фудзисава Фармасьютикал Ко, ЛтД
Publication of RU93004484A publication Critical patent/RU93004484A/en
Application granted granted Critical
Publication of RU2128172C1 publication Critical patent/RU2128172C1/en

Links

Claims (1)

Настоящее изобретение относится к производным пиразола и их фармацевтически приемлемым солям, обладающим противовоспалительной, болеутоляющей и противотромбозной активностью, к способам их получения и к фармацевтическим композициям, содержащим вышеупомянутые соединения в качестве активного ингредиента. Эти соединения могут применяться для профилактики и/или лечения воспалительных заболеваний, различных болей, коллагеноза, различных заболеваний иммунной системы и тромбозов в человеческом организме или у животного.The present invention relates to pyrazole derivatives and their pharmaceutically acceptable salts having anti-inflammatory, analgesic and anti-thrombotic activity, to methods for their preparation and to pharmaceutical compositions containing the above-mentioned compounds as an active ingredient. These compounds can be used for the prevention and / or treatment of inflammatory diseases, various pains, collagenosis, various diseases of the immune system and thrombosis in the human body or in an animal.
RU93004484A 1992-02-05 1993-02-04 Pyrazole derivatives or their pharmaceutically acceptable salts RU2128172C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9202442.1 1992-02-05
GB929202442A GB9202442D0 (en) 1992-02-05 1992-02-05 Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
GB9220427.0 1992-09-28
GB929220427A GB9220427D0 (en) 1992-09-28 1992-09-28 Pyrazole derivatives processes for preparation thereof and pharmaceutical composition comprising the same

Publications (2)

Publication Number Publication Date
RU93004484A true RU93004484A (en) 1995-05-20
RU2128172C1 RU2128172C1 (en) 1999-03-27

Family

ID=26300272

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93004484A RU2128172C1 (en) 1992-02-05 1993-02-04 Pyrazole derivatives or their pharmaceutically acceptable salts

Country Status (14)

Country Link
EP (1) EP0554829B1 (en)
JP (1) JPH05246997A (en)
KR (1) KR100252151B1 (en)
CN (1) CN1045767C (en)
AT (1) ATE217613T1 (en)
AU (1) AU663149B2 (en)
CA (1) CA2088835A1 (en)
DE (1) DE69331920T2 (en)
ES (1) ES2173875T3 (en)
HU (2) HUT63392A (en)
IL (1) IL104311A (en)
MX (1) MX9300579A (en)
PH (1) PH30916A (en)
RU (1) RU2128172C1 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2690440B1 (en) * 1992-04-27 1995-05-19 Rhone Poulenc Agrochimie Arylpyrazoles fungicides.
FR2711140B1 (en) * 1993-10-12 1996-01-05 Sanofi Sa 1-Naphtylpyrazole-3-substituted carboxamides active on neurotensin, their preparation, pharmaceutical compositions containing them.
US6492411B1 (en) 1993-11-30 2002-12-10 G. D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5475018A (en) * 1993-11-30 1995-12-12 G. D. Searle & Co. 1,5-diphenyl pyrazole compounds for treatment of inflammation
US6716991B1 (en) 1993-11-30 2004-04-06 G. D. Searle & Co. Process for preparing a substituted pyrazolyl benzenesulfonamide for the treatment of inflammation
US5466823A (en) * 1993-11-30 1995-11-14 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides
CA2177576C (en) * 1993-11-30 1999-10-26 John J. Talley Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
US5616601A (en) * 1994-07-28 1997-04-01 Gd Searle & Co 1,2-aryl and heteroaryl substituted imidazolyl compounds for the treatment of inflammation
US6613789B2 (en) 1994-07-28 2003-09-02 G. D. Searle & Co. Heterocyclo-substituted imidazoles for the treatment of inflammation
AU3815495A (en) * 1994-11-08 1996-05-31 Eisai Co. Ltd. Pyrazole derivatives exhibiting anti-inflammatory and analgesic effects
BR9609043A (en) * 1995-05-25 1999-02-23 Searle & Co Method of preparing 3 halo here 1h pyrazoles
US5756529A (en) * 1995-09-29 1998-05-26 G.D. Searle & Co. Substituted pyrazolyl benzenesulfonamides for use in veterinary therapies
GB9520584D0 (en) * 1995-10-09 1995-12-13 Fujisawa Pharmaceutical Co Pyrazole derivatives,processes for preparation thereof and pharmaceutical composition comprising the same
ID21775A (en) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical COMPOUND 1-PHENILPIRAZOL COMPOUNDS AND THE USE OF PHARMACIES
EA003056B1 (en) * 1996-12-23 2002-12-26 Дюпон Фармасьютикалз Компани NITROGEN CONTAINING HETEROAROMATICS AS FACTOR Xa INHIBITORS, PHARMACEUTICAL COMPOSITION AND METHOD OF USE
ZA985247B (en) * 1997-06-19 1999-12-17 Du Pont Merck Pharma Guanidine mimics as factor Xa inhibitors.
US6339099B1 (en) 1997-06-20 2002-01-15 Dupont Pharmaceuticals Company Guanidine mimics as factor Xa inhibitors
AUPO941497A0 (en) * 1997-09-24 1997-10-16 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
AU750356B2 (en) * 1997-09-24 2002-07-18 Fujisawa Pharmaceutical Co., Ltd. 1,5-diphenylpyrazole derivatives
CA2314401A1 (en) * 1997-12-22 1999-07-01 Du Pont Pharmaceuticals Company Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
US6271237B1 (en) 1997-12-22 2001-08-07 Dupont Pharmaceuticals Company Nitrogen containing heteromatics with ortho-substituted P1s as factor Xa inhabitors
DE19816880A1 (en) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma New diaryl substituted heterocyclic compounds are AMPA receptor antagonists useful in treatment of neurodegenerative disorders and cerebral ischemia
KR19990080440A (en) * 1998-04-17 1999-11-05 성재갑 Novel Pyrazole Derivatives
KR19990085450A (en) * 1998-05-18 1999-12-06 성재갑 New MEK Protein Inhibitors with Pyrazole Structure
US6294558B1 (en) 1999-05-31 2001-09-25 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
US6727238B2 (en) 1998-06-11 2004-04-27 Pfizer Inc. Sulfonylbenzene compounds as anti-inflammatory/analgesic agents
DE19904391A1 (en) * 1999-02-04 2000-08-10 Bayer Ag Pyrazole alkyl amides
DE60011100T2 (en) * 1999-08-27 2005-06-16 Abbott Laboratories, Abbott Park SULFONYLPHENYLPYRAZOLE COMPOUNDS USED AS COX-HEMMER
BR0016031A (en) 1999-12-03 2002-07-23 Pfizer Prod Inc Heterocycloalkylsulfonyl pyrazole derivatives as anti-inflammatory / analgesic agents
DE60001623T2 (en) 1999-12-03 2003-12-18 Pfizer Products Inc., Groton Sulfamoyl heteroaryl pyrazole compounds for use as an analgesic / anti-inflammatory agent
ES2208227T3 (en) 1999-12-03 2004-06-16 Pfizer Products Inc. HETEROARILFENILPIRAZOL COMPOUNDS AS ANTI-INFLAMMATORY / ANALGESIC AGENTS.
DE60004001T2 (en) 1999-12-03 2004-04-15 Pfizer Products Inc., Groton Acetylene derivatives for use as an analgesic or anti-inflammatory
CN1321112C (en) * 2000-03-24 2007-06-13 欧洲凯尔特股份有限公司 Aryl substituted pyrazoles, triazoles and tetrazoles as sodium channel blocker
DE60204823T2 (en) 2001-07-05 2005-12-29 Pfizer Products Inc., Groton Heterocyclo-alkylsulfonyl-pyrazoles as anti-inflammatory / analgesic agents
GT200200183A (en) 2001-09-28 2003-05-23 PROCEDURE TO PREPARE DERIVATIVES OF HETEROCICLOALQUILSULFONIL PIRAZOL
WO2003037336A1 (en) 2001-11-02 2003-05-08 Pfizer Products Inc. 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
BR0311267A (en) 2002-05-24 2005-05-10 Pharmacia Corp Synthesis of pyrazoles
AU2003279622A1 (en) 2002-06-28 2004-01-19 Nitromed, Inc. Oxime and/or hydrazone containing nitrosated and/or nitrosylated cyclooxigenase-2 selective inhibitors, compositions and methods of use
US20060079566A1 (en) 2003-10-03 2006-04-13 Ching-Shih Chen PDK-1/Akt signaling inhibitors
SI1696907T1 (en) * 2003-10-03 2013-12-31 The Ohio State University Research Foundation Pdk-1/akt signaling inhibitors
JP2007518686A (en) * 2003-10-17 2007-07-12 田辺製薬株式会社 High conductance calcium-sensitive K channel opener
FR2869905B1 (en) * 2004-05-10 2008-09-05 Sanofi Synthelabo PROCESS FOR PREPARING ESTER OF 1,5-DIPHENYLPYRAZOLE CARBOXYLIC ACID
US8039502B2 (en) 2007-07-24 2011-10-18 The Ohio State University Research Foundation Anti-infective agents against intracellular pathogens
DK2221298T3 (en) * 2007-11-13 2013-11-18 Taisho Pharmaceutical Co Ltd phenylpyrazole
DE102008015033A1 (en) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituted (pyrazolyl-carbonyl) imidazolidinones and their use
DE102008015032A1 (en) 2008-03-17 2009-09-24 Aicuris Gmbh & Co. Kg Substituted pyrazolamides and their use
DE102008062878A1 (en) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituted furancarboxamides and their use
DE102008062863A1 (en) 2008-12-17 2010-06-24 Aicuris Gmbh & Co. Kg Substituted (thiophenyl-carbonyl) imidazolidinones and their use
US20120108823A1 (en) 2009-04-22 2012-05-03 The Ohio State University Research Foundation Anti-francisella agents
DE102009036604A1 (en) 2009-07-30 2011-02-03 Aicuris Gmbh & Co. Kg Substituted bis-arylpyrazolamides with terminal primary amide functionality and their use
PH12013500467A1 (en) * 2010-09-21 2013-04-29 Eisai R&D Man Co Ltd Pharmaceutical composition
DE102011055815A1 (en) 2011-11-29 2013-05-29 Aicuris Gmbh & Co. Kg Carboxamide-substituted heteroaryl-pyrazoles and their use
DE102012016908A1 (en) 2012-08-17 2014-02-20 Aicuris Gmbh & Co. Kg Tris (hetero) aryl-pyrazoles and their use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1130808A (en) * 1979-10-05 1982-08-31 Ronald G. Micetich 3-(or 5-) trifluoromethyl-1-aryl pyrazoles
US4826868A (en) * 1986-05-29 1989-05-02 Ortho Pharmaceutical Corporation 1,5-Diaryl-3-substituted pyrazoles pharmaceutical compositions and use
AU611437B2 (en) * 1987-05-29 1991-06-13 Ortho Pharmaceutical Corporation Pharmacologically active 2- and 3-substituted (1',5'-diaryl-3-pyrazolyl)-n-hydroxypropanamides and method for synthesizing the same
PH27357A (en) * 1989-09-22 1993-06-21 Fujisawa Pharmaceutical Co Pyrazole derivatives and pharmaceutical compositions comprising the same
FR2665898B1 (en) * 1990-08-20 1994-03-11 Sanofi DERIVATIVES OF AMIDO-3 PYRAZOLE, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
JPH08181316A (en) * 1994-12-22 1996-07-12 Mitsubishi Electric Corp Semiconductor device and manufacturing method thereof

Similar Documents

Publication Publication Date Title
RU93004484A (en) DERIVATIVES OF PYRAZOLES, METHOD OF THEIR PRODUCTION AND CONTAINING THEIR PHARMACEUTICAL COMPOSITIONS
EP0098743B1 (en) Phenyl alpha-acyloxyacetamide derivates and their therapeutic use
EG20001A (en) Process for preparing of novel hydrox-amic acid and N-hydroxyurea derivatives and their use
ES8603870A1 (en) Derivatives of 2,2'-iminobisethanol.
ATE336997T1 (en) FULVIC ACID AND ITS USE IN THE TREATMENT OF VARIOUS MEDICAL CONDITIONS
DE69521536D1 (en) Compositions containing G-CSF and a TNF binding protein
SE8002322L (en) Means for the treatment of inflammatory bowel diseases
ATE135909T1 (en) METHOD FOR TREATING ACNE
HUP9802897A2 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
DE2967356D1 (en) Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
ATE458471T1 (en) FORMULATIONS CONTAINING POVIDONE IODINE FOR THE TREATMENT OF WOUNDS
RU2001118854A (en) OPTICALLY ACTIVE DERIVATIVE OF Pyridyl-4H-1,2,4-Oxadiazine AND ITS APPLICATION FOR TREATMENT OF VASCULAR DISEASES
DE69103773D1 (en) DERIVATIVES OF HYDROXAMIC ACID INHIBIT THE LIPOXYGENASE.
ATE393152T1 (en) PHTALAZINE DERIVATIVES WITH ANGIOGENESIS INHIBITING EFFECT
HUP9901659A2 (en) Use of flupirtin for producing pharmaceutical compositions suitable for the prevention and treatment of diseases which are associated with damage to the haemopoietic cell system
FR2564831B3 (en) NOVEL DERIVATIVES OF AROYL- OR HYDROAROYL N-ALCOYL PYRROLYL-2 CARBOXYLIC ACIDS AND NEW IMMUNO-SUPPRESSIVE PHARMACEUTICAL COMPOSITIONS
DK0814813T3 (en) Use of penciclovir for the treatment of human herpes virus-8
HUT60736A (en) Process for producing derivatives of 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid and pharmaceutical compositions comprising same as active ingredient
ITMI910133A0 (en) SALT DERIVATIVES OF GLYCERIL PHOSPHORIL MYOINOSITOL WITH THERAPEUTIC ACTIVITY PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
RU92016559A (en) DIALCOXY-PYRIDINYLBENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING OR TREATMENT, METHOD FOR PRODUCING THEM, USE AND INTERMEDIATE COMPOUNDS
MX9605153A (en) Pharmaceutical agents for the treatment of acute and chronic inflammatory diseases.
TH16370A (en) Diaryl compounds